staurosporine aglycone has been researched along with Anxiety Neuroses in 2 studies
staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gudasheva, TA | 1 |
| Povarnina, PY | 1 |
| Koliasnikova, KN | 1 |
| Alyaeva, AG | 1 |
| Vorontsova, ON | 1 |
| Seredenin, SB | 1 |
| Shah, AP | 1 |
| Carreno, FR | 1 |
| Wu, H | 1 |
| Chung, YA | 1 |
| Frazer, A | 1 |
2 other studies available for staurosporine aglycone and Anxiety Neuroses
| Article | Year |
|---|---|
The Anxiolytic Effect of the Neuropeptide Cycloprolylglycine Is Mediated by AMPA and TrkB Receptors.
Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Brain-Derived Neurotrophic Factor; Carbazoles; Enzy | 2020 |
Role of TrkB in the anxiolytic-like and antidepressant-like effects of vagal nerve stimulation: Comparison with desipramine.
Topics: Adrenergic Uptake Inhibitors; Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiet | 2016 |